Culture of low passage colorectal cancer cells and demonstration of variation in selected tumour marker expression

Cytotechnology

Volumn 66, Issue 3, 2014, Pages 481-491

  Arul, Melanie ^a   Roslani, April Camilla ^a   Ng, Colin Leong Liong ^b   Cheah, Swee Hung ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Fertility Centre   (Malaysia)

Author keywords

Cancer; Cell; Colorectal; Culture; Immunocytochemistry

Indexed keywords

ANTIGEN; ANTIINFECTIVE AGENT; C2 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MICROBIAL CONTAMINATION; PRIMARY TUMOR; PROTEIN EXPRESSION; TUMOR BIOPSY;

EID: 84899086718     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-013-9600-4     Document Type: Article

References (43)

1. ATCC (2007) Passage number effects in cell lines. (American Type Culture Collection) ATCC Technical Bulletin No. 7
2. Baten A, Sakamoto K, Shamsuddin AM (1992) Long-term culture of normal human colonic epithelial cells in vitro. FASEB 6:2726-2734
3. Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI (2009) Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Cancer Genomics Proteomics 6:19-29
4. Briske-Anderson MJ, Finley JW, Newman SM (1997) Influence of culture time and passage number on morphological and physiological development of Caco-2 cells. In: Proceedings of the society for experimental biology and medicine, vol 3. pp 248-257
5. Burdall SE, Hanby AM, Lansdown MRJ, Speirs V (2003) Breast cancer cell lines: friend or foe? Breast Cancer Res 5:89-95
6. Campbell LL, Polyak K (2007) Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6:2332-2338
7. Chang-Liu CM, Woloschak GE (1997) Effect of passage number on cellular response to DNA-damaging agents: cell survival and gene expression. Cancer Lett 26:77-86
8. Duffy MJ, Van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43:1348-1360
9. Esquenet M, Swinnen JV, Heyns W, Verhoeven G (1997) LNCaP prostatic adenocarcinoma cells derived from high and low passage numbers display divergent responses not only to androgens but also to retinoids. J Steroid Biochem Mol Biol 62:391-399
10. Failli A, Consolini R, Legitimo A, Spisni R, Castagna M, Romamini A, Crimaldi G, Miccoli P (2009) The challenge of culturing human colorectal tumor cells: establishment of a cell culture model by the comparison of different methodological approaches. Tumori 95:343-347
11. Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38:2651-2660
12. Gibson PR, van de Pol E, Maxwell LE, Gabriel A, Doe WF (1989) Isolation of colonic crypts that maintain structural and metabolic viability in vitro. Gastroenterology 96:283-291
13. Hammarström S (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Cancer Biol 9:67-81
14. Heppner GH (1984) Tumor heterogeneity. Cancer Res 44:2259-2265
15. Heppner GH, Miller BE (1983) Tumor heterogeneity: biological implications and therapeutic consequences. Cancer Metastasis Rev 2:5-23
16. Hu DN, Hwang SM, Lin XZ, Yang PY, Tsai CH, Huang Q, Huang HY, Hwang MH (2007) Isolation and characterization of two novel colon cancer cell lines from Chinese patients. In Vitro Cell Dev Biol Anim 43:105-108
17. Iwasa Y, Michor F (2011) Evolutionary dynamics of intratumor heterogeneity. PLoS One 6:e17866. doi: 10.1371/journal.pone.0017866
18. Iznaga-Escobar N, Ramos-Suzarte M, Morales-Morales A, Torres-Arocha L, Rodríguez-Mesa N, Pérez-Rodriguez R (2004) (99 m)Tc-labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization. Methods Find Exp Clin Pharmacol 26:687-696
19. Kirkland SC, Bailey IG (1986) Establishment and characterization of six human colorectal adenocarcinoma cell lines. Br J Cancer 53:779-785
20. Lacroix M, Leclercq G (2004) Relevance of breast cancer cell lines as models for breast tumors: and update. Breast Cancer Res Treat 83:249-289
21. Li X, Lewis MT, Gutierrez CC, Osborne K, Wu M, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100:672-679
22. Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J (2000) Tumor cells and the onset of cancer. In: Freeman WH (ed) Molecular cell biology, 4th edn. W. H. Freeman and Company, New York
23. Macleod KG, Langdon SP (2004) Essential techniques of cancer cell culture in cancer cell culture: methods and protocol. Human Press Inc, New Jersey
24. MacLeod RAF, Dirks AF, Willy G, Matsuo Y, Kaufmann M, Milch H, Drexler HG (1999) Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer 83:555-563
25. Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 1805:105-117
26. Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12:323-334. doi: 10.1038/nrc3261
27. NCI (2012) Singled out: researchers look to single cells for cancer insights. National Cancer Institute. http://www.cancer.gov/ncicancerbulletin/ 091812/page7
28. Nowell PC (1986) Mechanisms of tumor progression. Cancer Res 46:2203-2207
29. Ogino S, Fuchs CS, Giovannucci E (2012) How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Expert Rev Mol Diagn 12:621-628
30. Paraskeva C, Buckle BG, Sheer D, Wigley CB (1984) The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int J Cancer 34:49-56
31. Paraskeva C, Finerty S, Mountford RA, Powell SC (1989) Specific cytogenetic abnormalities in two new human colorectal adenoma-derived epithelial cell lines. Cancer Res 49:1282-1286
32. Perkins TJ, Swain PS (2009) Strategies for cellular decision-making. Mol Syst Biol 5:12
33. Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM, Morrison SJ (2010) Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18:510-523
34. Rubin H (2001) Selected cell and selective microenvironment in neoplastic development. Cancer Res 61:799-807
35. Rubin H (2005) Degrees and kinds of selection in spontaneous neoplastic transformation: an operational analysis. Proc Natl Acad Sci USA 102:9276-9281
36. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F (2005) The Caco-2 cell line as a model of the intestinal barrier; influence of cell and culture related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21:1-26
37. Shackleton M, Quintana E, Fearon ER, Morrison SJ (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138:822-829. doi: 10.1016/j.cell.2009.08.017
38. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA, Wong K, Brandstetter K, Wittner B, Ramaswamy S, Classon M, Settleman J (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141:69-80
39. Stockholm D, Benchaouir R, Picot J, Rameau P, Neildez TMA, Landini G, Laplace-Builhé C, Paldi A (2007) The origin of phenotypic heterogeneity in a clonal cell population in vitro. PLoS ONE 2:e394
40. Stuelten CH, Busch JI, Tang BW, Flanders KC, Oshima A, Sutton E, Karpova TS, Roberts AB, Wakefield LM, Niederhuber JE (2010) Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-β mediated mechanism in a mouse xenograft model of breast cancer. PLoS ONE 5:e9832. doi: 10.1371/journal.pone.0009832
41. Wenger SL, Senft JR, Sargent LM, Bamezai R, Bairwa N, Grant SG (2004) Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization. Biosci Rep 24:631-639
42. WHO (2011) World Health Organization - Cancer. http://www.who.int/ mediacentre/factsheets/fs297/en/index.html
43. Yu H, Cook TJ, Sinko PJ (1997) Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages. Pharm Res 14:757-762